These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 6814969)
41. [Outcome of a pregnancy made possible by the use of human gonadotropin]. Dellestable P; Barrucand D; Vert P; Toussain P; Hartemann P Bull Fed Soc Gynecol Obstet Lang Fr; 1968; 20(5):473-6. PubMed ID: 5759128 [No Abstract] [Full Text] [Related]
42. Clinical methods for the assessment of the sensitivity of the adenopituitary and ovary. Horský J; Stroufová A; Herzmann J Czech Med; 1978; 1(3):153-5. PubMed ID: 359286 [No Abstract] [Full Text] [Related]
43. [Combined therapy of male subfertility with HMG and HCG]. Petres J; Arbogast R Fortschr Androl; 1974; 3():202-3. PubMed ID: 4469544 [No Abstract] [Full Text] [Related]
44. ["Brief" progestational phase and therapy to prolong it]. Salvadori B Minerva Ginecol; 1968 Feb; 20(4):375-7. PubMed ID: 5738736 [No Abstract] [Full Text] [Related]
45. [Practical aspects of the treatment of female sterility with human gonadotropins]. Cagnazzo G Minerva Ginecol; 1967 May; 19(10):560-2. PubMed ID: 5605259 [No Abstract] [Full Text] [Related]
48. [HCG-like activity in the cellular cytosol of some organs after hormone administration in vivo (author's transl)]. Figarová V; Presl J; Krabec Z Cesk Gynekol; 1974 Dec; 39(10):768-72. PubMed ID: 4442163 [No Abstract] [Full Text] [Related]
49. Recombinant hCG (OVIDREL) and recombinant interferon-(beta)1a (REBIF). (No. 13 in a series of articles to promote a better understanding of the use of genetic engineering). Fonjallaz P; Loumaye E J Biotechnol; 2001 May; 87(3):279-81. PubMed ID: 11411454 [No Abstract] [Full Text] [Related]
50. [HCG must remain]. Rolland R Ned Tijdschr Geneeskd; 1985 May; 129(21):1010. PubMed ID: 4040219 [No Abstract] [Full Text] [Related]
51. Human chorionic gonadotropin (HCG) in treatment of obesity. Hutton JH; Creticos AP IMJ Ill Med J; 1967 Nov; 132(5):693-5. PubMed ID: 4383998 [No Abstract] [Full Text] [Related]
52. [Treatment of phimosis with human chorionic gonadotropin]. Noack R; Salomon B Z Arztl Fortbild (Jena); 1990; 84(11):547-9; discussion 550. PubMed ID: 2396434 [No Abstract] [Full Text] [Related]
53. Response of HMG-HCG administration on the vaginal epithelium, cervical mucus, endometrium and ovary. Silló-Seidl G Acta Eur Fertil; 1973 Sep; 4(3):109-12. PubMed ID: 4788936 [No Abstract] [Full Text] [Related]
55. Biologic effect of a hybrid preparation of human chorionic gonadotropin in human subjects. Rosemberg E Reproduccion; 1982; 6(2):117-32. PubMed ID: 6814969 [TBL] [Abstract][Full Text] [Related]
56. First demonstration of induction of ovulation with a hybrid human chorionic gonadotropin compound (AB1ER-CR-2XY). Rosemberg E; Cortes-Prieto J Fertil Steril; 1983 Dec; 40(6):790-7. PubMed ID: 6418576 [TBL] [Abstract][Full Text] [Related]
57. Effect of a partially desialylated human chorionic gonadotropin preparation (Desialo hCG) on ovarian function. Rosemberg E Reproduccion; 1983; 7(1-2):33-45. PubMed ID: 6413269 [TBL] [Abstract][Full Text] [Related]